Imaging Informatics Provider Announces FDA Clearance of New Platform
By MedImaging International staff writers Posted on 08 Sep 2015 |
A new clinical decision support platform for enterprise Picture Archiving and Communication System (PACS) and Vendor Neutral Archives (VNA) has received US Food and Drug Administration (FDA) 510 (k) clearance.
The platform was designed to integrate and align with enterprise PACS and VNA systems using industry-standard formats such as the US American College of Radiology (ACR) Imaging 3.0 initiative.
The platform was developed by HealthMyne (Madison, WI, USA), an imaging informatics company, and is intended to help radiologists provide diagnostic imaging data to clinicians before and after performing an imaging exam during the clinical workflow.
HealthMyne’s image data mining platforms can help radiologist and oncologists increase their workflow efficiency by automating data capture, and structured reports. The platform will provide integrated patient progression timelines, and analytics and enable clinicians to compare data for an individual patient with a patient cohort. HealthMyne’s analytic tools are also intended to help researchers explore quantitative imaging biomarkers, and support improved clinical trials of innovative therapies.
Praveen Sinha, CEO of HealthMyne, said, “Having a strong diagnostic imaging platform cleared by the FDA is the first step in our vision of bringing imaging informatics to mainstream healthcare. Significant achievements are being realized elsewhere through clinical data aggregation and analysis, yet imaging has gone largely untapped. As an example, the potential impact of streamlined patient cohort comparison on personalized medicine is truly exciting.”
Related Links:
HealthMyne
The platform was designed to integrate and align with enterprise PACS and VNA systems using industry-standard formats such as the US American College of Radiology (ACR) Imaging 3.0 initiative.
The platform was developed by HealthMyne (Madison, WI, USA), an imaging informatics company, and is intended to help radiologists provide diagnostic imaging data to clinicians before and after performing an imaging exam during the clinical workflow.
HealthMyne’s image data mining platforms can help radiologist and oncologists increase their workflow efficiency by automating data capture, and structured reports. The platform will provide integrated patient progression timelines, and analytics and enable clinicians to compare data for an individual patient with a patient cohort. HealthMyne’s analytic tools are also intended to help researchers explore quantitative imaging biomarkers, and support improved clinical trials of innovative therapies.
Praveen Sinha, CEO of HealthMyne, said, “Having a strong diagnostic imaging platform cleared by the FDA is the first step in our vision of bringing imaging informatics to mainstream healthcare. Significant achievements are being realized elsewhere through clinical data aggregation and analysis, yet imaging has gone largely untapped. As an example, the potential impact of streamlined patient cohort comparison on personalized medicine is truly exciting.”
Related Links:
HealthMyne
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
Cardiovascular disease remains the leading cause of death in women worldwide, responsible for about nine million deaths annually. Despite this burden, symptoms and risk factors are often under-recognized... Read more
AI Hybrid Strategy Improves Mammogram Interpretation
Breast cancer screening programs rely heavily on radiologists interpreting mammograms, a process that is time-intensive and subject to errors. While artificial intelligence (AI) models have shown strong... Read moreMRI
view channel
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read moreUltrasound
view channel
Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
Meningitis, an inflammation of the membranes surrounding the brain and spinal cord, can be fatal in infants if not diagnosed and treated early. Even when treated, it may leave lasting damage, such as cognitive... Read more
Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
Ultrasound imaging is a vital diagnostic technique used to visualize internal organs and tissues in real time and to guide procedures such as biopsies and injections. When paired with photoacoustic imaging... Read moreNuclear Medicine
view channel
PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more
New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
Nuclear medicine scans like single-photon emission computed tomography (SPECT) allow doctors to observe heart function, track blood flow, and detect hidden diseases. However, current detectors are either... Read more
Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read moreGeneral/Advanced Imaging
view channel
New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
In pancreatic cancer, detecting whether the disease has spread to other organs is critical for determining whether surgery is appropriate. If metastasis is present, surgery is not recommended, yet current... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more